Cancer Drug Delivery

Track Chair(s)

• 

  Elizabeth Barker, PhD

  Assistant Professor
  University of Tennessee
  Knoxville, Tennessee, United States
• 

  Jyothi Menon, PhD

  Associate Professor
  Texas A&M University
  College Station, Texas, United States

Session Chair(s)

• 

  Ali Salifu

  Assistant Professor
  Boston College
  Chestnut Hill, Massachusetts, United States
• JJ

  Johnson John, PhD

  Assistant Professor
  Terasaki Institute for Biomedical Innovation, California, United States

Presentations:

• 12:30 PM - 12:45 PM PDT

  Bifunctional antibody-conjugated nano-therapeutics for combination drug delivery
  

  Presenting Author: Tanmoy Saha, PhD – Brigham and Women's Hoapital, Harvard Medical School

  Primary Investigator: Tanmoy Saha, PhD – Brigham and Women's Hoapital, Harvard Medical School
• 12:45 PM - 1:00 PM PDT

  Age-associated changes of liver macrophage populations affect nanomedicine delivery
  

  Presenting Author: Yifan wang, PhD – The University of Texas MD Anderson Cancer Center

  Co-Author: Shiyan Dong – The University of Texas MD Anderson Cancer Center

  Co-Author: Yifan Ma, PhD – The University of Texas MD Anderson Cancer Center

  Co-Author: Weiye Deng – The University of Texas MD Anderson Cancer Center

  Co-Author: Betty Kim – The University of Texas MD Anderson Cancer Center

  Primary Investigator: Wen Jiang – The University of Texas MD Anderson Cancer Center
• 1:00 PM - 1:15 PM PDT

  Light-Responsive Nanocomposite Scaffolds for Controlled Delivery of Prodigiosin for Triple-Negative Breast Cancer Therapy
  

  Presenting Author: Maria Chinyerm E. Onyekanne, PhD – Boston College

  Co-Author: Tom A. A. Buckman – Boston College

  Co-Author: Vanessa Uzonwanne – Boston College

  Co-Author: John Obayemi, PhD – Department of Biomedical Engineering, Worcester Polythecnic Institute

  Co-Author: Wole Soboyejo – Department of Engineering, SUNY Polytechnic Institute, Utica, NY

  Primary Investigator: Ali Salifu – Boston College
• 1:15 PM - 1:30 PM PDT

  Development of novel Ac-225 loaded gold nanoparticles for radioisotope cancer therapy
  

  Presenting Author: Ayaka Otsuka, ME – University of Tokyo

  Co-Author: Noriko Nakamura – University of Tokyo

  Co-Author: Kenji Shimazoe – University of Tokyo

  Last Author: Seiichi Ohta – University of Tokyo
• 1:30 PM - 1:45 PM PDT

  The impact of peptide surface density on PD-L1 receptor inhibition as a therapeutic strategy for triple negative breast cancer
  

  Presenting Author: Naira Keshishian – Northeastern University

  Primary Investigator: Debra T. Auguste – Northeastern University

  Co-Author: Rudolf G. Abdelmessih – Northeastern University
• 1:45 PM - 2:00 PM PDT

  Antibody Modulation via Protein L-Linked Blockers for Precision Immunotherapy
  

  Presenting Author: Michael I. Henderson, B.A. – Oregon Health & Science University

  Co-Author: Michael Brasino, Ph.D. – University of Vermont

  Co-Author: Vaibhav Murthy, B.S. – Oregon Health & Science University

  Co-Author: Sean Speese, Ph.D. – Oregon Health & Science University

  Co-Author: Randall Armstrong, B.S. – Oregon Health & Science University

  Co-Author: Jason Ware, B.S. – Oregon Health & Science University

  Co-Author: Alexander Davies, D.V.M., Ph.D. – Oregon Health & Science University

  Primary Investigator: Stuart Ibsen, Ph.D. – Oregon Health & Science University